An 8-year-old girl presented with a 12-day history of progressive headache, fever, rhinorrhea and periorbital swelling. She was febrile with lethargy and nuchal rigidity. Her neurological exam noted bilateral oculomotor deficits in all directions consistent with cranial nerve III, IV and VI palsies. She had a normal afferent visual exam. She had decreased facial sensation to the left V1 territory. She had no other neurological deficits. Clinically, she was suspected to have sinusitis, meningitis and cavernous sinus thrombosis. MRI with gadolinium confirmed bilateral sphenoid and ethmoid sinusitis, thrombophlebitis of the cavernous sinuses and right internal jugular and right superior ophthalmic veins. MR angiogram revealed narrowing of both internal carotid arteries (ICA) at the petrous and cavernous segments with contrast studies showing narrowing and wall enhancement suggestive of arteritis (Figure 1). She received empiric intravenous (IV) ceftriaxone, metronidazole and vancomycin. Ceftriaxone was continued via a peripherally inserted central catheter (×6 weeks treatment). Metronidazole IV was administered (×10 days) followed by an additional 34 days of oral therapy. Vancomycin IV was stopped after 3 days when blood culture and sensitivities returned. Heparin IV was started, transitioned to enoxaparin prior to discharge and discontinued after resolution of the thrombus. Otolaryngology performed an urgent sinus decompression surgery. Lumbar puncture demonstrated a normal opening pressure with CSF leukocytes 25 × 106 cells/L (normal <5 × 106 cells/L) and normal CSF erythrocytes, protein and glucose. Blood culture (drawn prior to antibiotics) identified Streptococcus intermedius. Given her ICA narrowing and evidence for arteritis, and following a lack of clinical improvement after 24 hours of antibiotics, infectious disease consultation and consideration of potential risk/benefit, she was treated with methylprednisolone 30 mg/kg/day IV (×5 days) followed by an oral prednisone taper over 4 weeks. Two days after treatment, she showed improvement in periorbital swelling and resolution of fever, meningismus and facial sensory deficit as well as near-complete resolution of her oculomotor deficits. She was discharged home after 10 days.
Repeat imaging 8 weeks later demonstrated resolution of her right ICA narrowing and mild residual left ICA narrowing. Her right internal jugular and superior ophthalmic vein thrombi had resolved. Her neurological examination was normal. A complete thrombotic workup revealed a heterozygous variant for F5 p. Arg534Gln (Factor V Leiden).
Over one-third of children with acute bacterial meningitis show MRI evidence of an acute ischemic stroke (AIS). Reference Dunbar, Shah and Shinde1 Pneumococcal meningitis has been associated with AIS in 48% of children and 36% of adults. Reference Dunbar, Shah and Shinde1,Reference Schut, Lucas, Brouwer, Vergouwen, vand der Ende and van de Beek2
Infectious vasculitis has been reported in a child and adults with pneumococcal meningitis. Reference Mukherjee and Saha3,Reference Khedher, Sma, Slama, Fraj, Hachfi and Boussarsar4 The child demonstrated AIS with resulting vasculitis in the first week after initiation of antibiotics. Reference Mukherjee and Saha3 There are reports of adults with pneumococcal meningitis who demonstrate delayed AIS with vasculopathy who, after an initial clinical improvement, abruptly declined 7–19 days later. Arteriopathy involving large and small penetrating arteries is documented in adults with pneumococcal meningitis. Reference Pfister, Feiden and Einhaupl5–Reference Pugin, Copin, Goodyear, Landis and Gasche7
Corticosteroid use has been associated with reduced mortality in pneumococcal meningitis and clinical/radiologic improvement in presumed central nervous system (CNS) vasculitis in the context of Streptococcus pneumoniae meningitis complicated by ischemic strokeReference D’Aniello, Rustici and Gramegna; Reference D’Aniello, Rustici and Gramegna11 however, there are no guidelines regarding their use in patients with MRI evidence of vessel involvement. We demonstrate a case where MR angiogram was essential to the diagnosis of CNS infectious vasculitis, the hallmarks of which are vessel wall enhancement and arterial stenoses. Reference Chan, Lin and Hsia12 As such, we illustrate that the use of vascular imaging in the setting of head and neck infections is useful for assessing stroke risk in these cases. Further, our decision to treat with corticosteroids (as well as the dose and taper schedule used) was based upon prior case reports of a child Reference Mukherjee and Saha3 and adult Reference Khedher, Sma, Slama, Fraj, Hachfi and Boussarsar4 with pneumococcal meningitis who progressed to AIS, both of whom were reported to show a beneficial response to subsequent corticosteroids. Currently, there are two ongoing clinical trials 8,9 evaluating the efficacy of high-dose corticosteroids in secondary stroke prevention in children with a focal cerebral arteriopathy-inflammatory type (FCA-I), which may share a common inflammatory pathophysiological underpinning to our case, although FCA-I is typically considered presumed viral in etiology. Reference Hui, Yau and Fung10 In contrast to the above studies, our patient received corticosteroids for primary stroke prevention, given the stenosis seen at the petrous and cavernous portion of the bilateral ICAs. Concern was raised about the risk for either hypoperfusion-related ischemic stroke or hyperacute arterial stroke associated with thrombosis formation due to abnormal flow distal to the ICA narrowing. No restricted diffusion was evident on MRI in our case. While the effects of the multiple treatments cannot be teased apart (i.e., urgent sinus decompression surgery, IV antibiotics, therapeutic anticoagulation and high dose corticosteroids), we nevertheless demonstrate that the addition of corticosteroids was associated with a positive clinical and radiologic outcome and avoidance of an acute ischemic stroke. Further research is required into the underlying cause and optimal treatment of patients with pneumococcal-associated vasculopathy to ensure that treatment is standardized and that the risk of subsequent ischemic stroke is considered in all patients with intracranial infection and inflammatory disease.
Acknowledgments
None.
Author contributions
RG – conceptualizing study, drafting and revising the manuscript. NW – drafting and revising the manuscript. MM – providing critical review of the manuscript. HM – conceptualizing study, drafting and revising the manuscript.
Funding statement
The authors have no relevant financial disclosures or conflicts of interest to report.
Written consent was obtained from the patient’s parents.
Competing interests
The authors declare no conflict of interest.